Aristotle Capital Management
MRK icon

Aristotle Capital Management’s Merck MRK Stock Holding History

Aristotle Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$845M Sell
6,578,570
-315,862
-5% -$37M 1.77% 19
2026
Q1 		$829M Sell
6,894,432
-386,461
-5% -$44.6M 1.74% 24
2025
Q4 		$766M Sell
7,280,893
-537,045
-7% -$50.4M 1.53% 37
2025
Q3 		$656M Sell
7,817,938
-317,614
-4% -$26.2M 1.27% 42
2025
Q2 		$644M Sell
8,135,552
-328,197
-4% -$26.1M 1.24% 41
2025
Q1 		$760M Sell
8,463,749
-224,584
-3% -$21M 1.51% 37
2024
Q4 		$864M Sell
8,688,333
-232,596
-3% -$24M 1.67% 32
2024
Q3 		$1.01B Sell
8,920,929
-19,713
-0.2% -$2.34M 1.84% 25
2024
Q2 		$1.11B Sell
8,940,642
-254,229
-3% -$32.7M 2.14% 15
2024
Q1 		$1.21B Sell
9,194,871
-292,467
-3% -$36M 2.25% 13
2023
Q4 		$1.03B Sell
9,487,338
-436,262
-4% -$45.3M 2.02% 18
2023
Q3 		$1.02B Sell
9,923,600
-235,022
-2% -$25.3M 2.2% 13
2023
Q2 		$1.17B Sell
10,158,622
-159,050
-2% -$18.1M 2.38% 10
2023
Q1 		$1.1B Sell
10,317,672
-99,860
-1% -$10.8M 2.3% 13
2022
Q4 		$1.16B Buy
10,417,532
+1,539,606
+17% +$157M 2.45% 9
2022
Q3 		$765M Buy
+8,877,926
New +$793M 1.69% 34
2018
Q2 		– Sell
-118
Closed -$6K – 192
2018
Q1 		$6K Buy
+118
New +$6.37K ﹤0.01% 215

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aristotle Capital Management's MRK Position: Q2 2026 in Review

Aristotle Capital Management reduced its Merck (MRK) stake by 4.6% in Q2 2026, selling an estimated $37M and leaving 6,578,570 shares worth $845M. The position accounts for 1.77% of the portfolio, ranked #19.

Aristotle Capital Management first reported a position in MRK in Q1 2018 and has held it in 17 quarters since. The position peaked at $1.21B in Q1 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aristotle Capital Management held 6,578,570 shares of Merck worth $845M as of Q2 2026.
  • Aristotle Capital Management sold 315,862 Merck shares in Q2 2026, an estimated $37M.
  • Merck made up 1.77% of Aristotle Capital Management's portfolio in Q2 2026, its #19 holding.
  • Aristotle Capital Management first reported a position in Merck in Q1 2018 and has held it in 17 quarters since.
  • Aristotle Capital Management's Merck position peaked at $1.21B in Q1 2024.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aristotle Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.